在重症患者中的Acinetobacter baumannii:复杂的感染变得复杂
Ilaria Cavallo1, Alessandra Oliva2, Rebecca Pages1
1Microbiology and Virology, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.
Frontiers in microbiology
|July 10, 2023
概括
Acinetobacter baumannii感染是一个日益增长的威胁,特别是在危急病患者中,由于广泛的抗菌素耐药性和生物膜形成. 迫切需要新的治疗策略来对抗这些具有挑战性的多重耐药性感染.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 宝曼尼菌 (Acinetobacter baumannii) 是一个重要的机会性病原体,特别是在医院环境中.
- 它导致严重的感染,如细菌病,肺炎和皮肤/软组织感染,死亡率高 (高达35%).
- 耐卡巴胺抗性杆菌 (Acinetobacter baumannii,CRAB) 的增加限制了治疗选择,使得素成为首要选择.
研究的目的:
- 审查Acinetobacter baumannii中当前的抗菌素耐药性模式.
- 讨论生物膜介导耐受性作为治疗挑战.
- 专注于弱势和重症患者中的Acinetobacter baumannii感染.
主要方法:
- 关于抗微生物药物耐药性的文献综述.
- 对生物膜形成机制和临床影响的分析.
- 关注高风险人群中Acinetobacter baumannii的治疗策略.
主要成果:
- 碳烯是第一线药物,但CRAB需要替代疗法,如素.
- 胆固醇单一治疗显示了CRAB感染的高失败率,表明需要组合治疗.
- Acinetobacter baumannii很容易在医疗器械上形成生物膜,使治疗复杂化,并促进多药性耐药性.
结论:
- 对Acinetobacter baumannii感染的有效治疗,特别是CRAB和产生生物膜的菌株,仍然是一个重大的临床挑战.
- 对CRAB感染的最佳抗生素组合需要进一步调查.
- 了解耐药性和生物膜机制对于开发新的治疗方法至关重要.
关键词:
这种细菌是Acinetobacter baumannii.生物膜是一种生物膜.癌症 癌症 癌症 癌症 癌症碳烯的使用方法塞菲德罗科尔 (Cefiderocol) 是一种科里斯 (Colistin) 是一个古老的龙是什么意思?龙是什么意思皮肤和软组织感染.更多相关视频
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
653
07:59Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
361
相关概念视频
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
17
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
17
01:30Pneumonia III: Complications and Assessment
274
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
274
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
4.3K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.3K
01:30Pneumonia I: Introduction
274
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
274
01:29Acute Respiratory Failure-V
166
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
166
01:28Pneumonia IV: Management
360
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
360